Bedfont Scientific Limited

Bedfont® appoints Michael Bencak to strengthen its position and accelerate growth

The NObreath® FeNO device offers a clear pathway to more effective asthma care, reducing over-reliance on blue inhalers.

Bedfont® Scientific Limited believes balanced teams drive better decision-making, stronger innovation, and long-term success.

Intermedical UK proudly delivers the 3,000th NObreath® FeNO device to the UK market.

coVita™ and Allergy Partners team up to improve asthma care in America

Smokerlyzer®, Gastrolyzer®, and NObreath® devices on show at the world's largest healthcare event.

Bedfont® is recognised for putting people first and scoops the AHM Health & Wellbeing Award.

Bedfont® Scientific Limited strengthens community safety with defibrillator donation.

Rbeck Healthtech Private completes registration for the NObreath® FeNO device, helping to improve asthma care across the region.

The NObreath® device enhances access to FeNO diagnostics in Mexico.